RUA Life Sciences (LON:RUA) Releases Earnings Results

RUA Life Sciences (LON:RUA) released its quarterly earnings data on Tuesday. The company reported GBX (0.33) earnings per share (EPS) for the quarter, Digital Look Earnings reports. RUA Life Sciences had a negative net margin of 3.26% and a negative return on equity of 2.03%.

RUA Life Sciences Stock Up 2.1%

LON RUA opened at GBX 19.40 on Friday. RUA Life Sciences has a 1 year low of GBX 10.42 and a 1 year high of GBX 26.80. The stock has a market capitalization of £12.04 million, a PE ratio of -2.61 and a beta of 0.96. The company has a debt-to-equity ratio of 18.95, a current ratio of 4.64 and a quick ratio of 7.32. The business’s 50-day moving average is GBX 19.96 and its 200 day moving average is GBX 16.

About RUA Life Sciences

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.